Canada - English - Health Canada

apotex inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 4mg - ondansetron (ondansetron hydrochloride dihydrate) 4mg - 5-ht3 receptor antagonists

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

genfar, s.a. - trimetoprim - trimetoprim....160,000mg / sulfametoxazol....800,000mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

genfar s.a - trimetoprima - trimetoprima....0.800g / sulfametoxasol....4.000g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

corporaciÓn bonima, s.a. de c.v. - trimetoprima - trimetoprima....160.00 mg / sulfametoxazol....800.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios la sante s.a.. - trimetoprima - trimetoprima....160.00 mg / sulfametoxazol....800.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

corporacion bonima, s.a. de c.v. - trimetoprima - trimetoprima....40.00mg / sulfametoxazol....200.00mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios ecar s.a. - trimetoprim - trimetoprim....800.0000 mg / sulfametoxasol....4,000.0000 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios ryan de colombia s.a.s - trimetoprim - trimetoprim....80.00 mg / sulfametoxazol....400.00 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metoclopramide hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: purified talc; stearic acid; macrogol 6000; pregelatinised maize starch; hypromellose; titanium dioxide; colloidal anhydrous silica; maize starch; microcrystalline cellulose - in adults (20 years and over): as an adjunct to x-ray examination of the stomach and duodenum. to assist in intestinal intubation. to control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. there is no clear benefit in motion sickness or other labyrinth disturbances. metoclopramide hydrochloride has been found useful in the management of gastric retention after gastric surgery. metoclopramide hydrochloride may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. once control of diabetes has been established by diet and/or insulin, metoclopramide hydrochloride should be discontinued.,young adults: the use of metoclopramide hydrochloride in patients under 20 years should be restricted to the following situations: severe intractable vomiting of known cause. vomiting associated with radiotherapy and intolerance to cytotoxic drugs. as an aid to gastrointestinal intubation

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metoclopramide hydrochloride, quantity: 5 mg - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; titanium dioxide; microcrystalline cellulose; macrogol 6000; purified talc; hypromellose; stearic acid; colloidal anhydrous silica - in adults (20 years and over): as an adjunct to x-ray examination of the stomach and duodenum. to assist in intestinal intubation. to control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. there is no clear benefit in motion sickness or other labyrinth disturbances. metoclopramide hydrochloride has been found useful in the management of gastric retention after gastric surgery. metoclopramide hydrochloride may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. once control of diabetes has been established by diet and/or insulin, metoclopramide hydrochloride should be discontinued.,young adults: the use of metoclopramide hydrochloride in patients under 20 years should be restricted to the following situations: severe intractable vomiting of known cause. vomiting associated with radiotherapy and intolerance to cytotoxic drugs. as an aid to gastrointestinal intubation